Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CE 26:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST003678 AN006039 The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST002422 AN003944 UBXD8 lipidomics from whole cells (Part 2) Cultured cells Human University of Arizona LC-MS
ST002421 AN003942 UBXD8 lipidomics from whole cells (Part 1) Cultured cells Human University of Arizona LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
ST001442 AN002410 Human Optic Nerve Glaucoma and Control Lipidomes Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST001269 AN002109 Exosomal lipids for classifying early and late stage non-small cell lung cancer Blood Human Cancer University of Kentucky MS(Dir. Inf.)
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
  logo